EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS

The aim of this study was to identify the most effective (in the clinical and pharmacoeconomic aspects) drug for the treatment of widespread progressing differentiated thyroid cancer (DTC) refractory to radioactive iodine in patients – residents of the Russian Federation.Materials and Methods. The b...

Descripció completa

Dades bibliogràfiques

Autors principals:	M. Yu. Frolov, V. A. Rogov
Format:	Artigo
Idioma:	Russo
Publicat:	IRBIS LLC 2017-05-01
Col·lecció:	Фармакоэкономика
Matèries:	lenvatinib sorafenib “cost-effectiveness” analysis budget impact analysis pharmacoeconomics thyroid cancer
Accés en línia:	https://www.pharmacoeconomics.ru/jour/article/view/177
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!